Five Prime(FPRX)

38.00 0.00 0.0%

今开:0.0昨收:38.0
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:1.769737102E9

Five Prime的最新讨论

Aidyn2020-02-07 15:44

$Five Prime(FPRX)$ 5元左右是很好的加仓位置。今年不少催化剂。很看好查看全文

美股滚雪球2020-01-30 12:35

xbi调整在即,我们近期会根据行情走势推出关注名单,建仓价格和仓位大小, $Sage Therapeutics(SAGE)$ /AFMD/ $Five Prime(FPRX)$ / $阿玛琳(AMRN)$ /LABD查看全文

旭日待东升2020-01-07 11:06

下周即将召开JP morgan大会,这里提几只会上可以关注的标的。$Clearside生物医学(CLSD)$ 之前冲高过度回落,昨日宣布参加JP morgan大会股价上涨20%。$Five Prime(FPRX)$ 标的目前仍处于被低估的状态,也将参加JP morgan大会。同样值得关注的还有:SRPT(MDD明星药企,目前已经绝对领先),TGTX(3...查看全文

chuminhua2019-11-17 00:23

11/9,致力于开发针对实体瘤的免疫调节剂和精准疗法的临床阶段生物技术公司Five PrimeTherapeutics$Five Prime(FPRX)$ ,在第34届癌症免疫治疗学会(SITC)年会上的海报展示中, 公布了CD80融合蛋白-FPT155用于治疗晚期实体瘤患者的Ⅰ期临床试验初步安全性数据。查看全文

知行健2018-09-13 21:20

$Five Prime Therapeutics, Inc. (FPRX)$ 一家临床阶段的生物技术公司,致力于发现和发展创新的蛋白质疗法,以改善严重疾病患者的生活。我们的每一个产品候选者都有一个创新的行动机制,并解决了PAT问题。需要更好的治疗的人群。我们的重点是免疫肿瘤学,在这个领域我们有临床,临床前,研究和发现...查看全文

WitnessBio2018-09-11 00:29

$Five Prime Therapeutics, Inc. (FPRX)$
$FPRX Completes P1 Safety Lead-In and Initiates P3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers查看全文

淘沙见金2017-11-08 22:28

$Five Prime Therapeutics, Inc.(FPRX)$ 这事太搞笑了,FPRX的管理层说SITC不应该把later breaker的摘要放出来,造成了不少的误会[吐血][吐血][吐血]。今早开会澄清了一下安全的数据, $百时美施贵宝(BMY)$ 也是选择继续试验。估计今天股价会开始恢复的。查看全文

淘沙见金2017-11-07 22:44

$Five Prime Therapeutics, Inc.(FPRX)$ 数据不好,股价直接腰斩。这是不是意味着CSF1R抗体这条路走不通?40的put要翻好几倍了。查看全文

乌七吗黑2017-11-07 22:35

$Five Prime Therapeutics, Inc.(FPRX)$ 我去,这下悲剧了[亏大了][亏大了][亏大了]查看全文

1 2 3 4 5

Five Prime的公告

$Five Prime(FPRX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-119360  Act: 33  Size: 28 KB 网页链接

$Five Prime(FPRX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-119362  Act: 33  Size: 28 KB 网页链接

$Five Prime(FPRX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-119370  Act: 33  Size: 28 KB 网页链接

$Five Prime(FPRX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-119330  Act: 33  Size: 28 KB 网页链接

$Five Prime(FPRX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-119341  Act: 33  Size: 28 KB 网页链接

$Five Prime(FPRX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-119342  Act: 33  Size: 28 KB 网页链接

$Five Prime(FPRX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-119352  Act: 33  Size: 28 KB 网页链接

$Five Prime(FPRX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-119353  Act: 33  Size: 28 KB 网页链接

$Five Prime(FPRX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-119305  Act: 33  Size: 19 KB 网页链接

$Five Prime(FPRX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000482  Act: 34  Size: 3 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49